Article info
PDFEthics
The right to treatment for self-inflicted conditions
- Correspondence to Dr Ofra Golan, The Unit for Genetic Policy and Bioethics, Gertner Institute for Epidemiology and Health Policy Research, Tel Hashomer 52621, Israel; ofrag{at}gertner.health.gov.il
Citation
The right to treatment for self-inflicted conditions
Publication history
- Received March 8, 2010
- Revised May 25, 2010
- Accepted June 13, 2010
- First published August 16, 2010.
Online issue publication
October 21, 2010
Article Versions
- Previous version (16 August 2010).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Other content recommended for you
- On the relevance of personal responsibility in priority setting: a cross-sectional survey among Norwegian medical doctors
- Personal responsibility for health as a rationing criterion: why we don’t like it and why maybe we should
- Ethical issues related to the access to orphan drugs in Brazil: the case of mucopolysaccharidosis type I
- Priority setting and personal health responsibility: an analysis of Norwegian key policy documents
- Ethics, economics, and public financing of health care
- Raising the profile of fairness and justice in medical practice and policy
- National health system cuts and triage decisions during the COVID-19 pandemic in Italy and Spain: ethical implications
- COVID-19 pandemic, the scarcity of medical resources, community-centred medicine and discrimination against persons with disabilities
- Distributive justice and the harm to medical professionals fighting epidemics
- Ethical issues in funding orphan drug research and development